Intervenciones neuropsicofarmacológicas en los trastornos parafílicos
Dr. Martín
Dr. Martín Mazzoglio y Nabar, Dr. Daniel Silva 2004;65:959-65. • Kafka MP, Hennen J. Psychostimulantaugmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilia-related disorders: a case series. J Clin Psychiatry 2000;61(9):664-70. • Kafka MP, Prentky R (1992). Fluoxetine treatment of non paraphilic sexual addictions and paraphilias in men. J Clin Psychiatry 53(10):351-8. • Kennedy SH, Eisfeld BS, Dickens SE, et al. Antidepressant-induced sexual dysfunctionduring treatment with moclobemide, paroxetine, sertraline and venlafaxine. J Clin Psychiatry 2000,61:276-81. • Khazaal Y, Zullino DF. Topiramate in thetreatment of compulsive sexual behavior: case report. BMC Psyciatry 2006;6:22. • Krueger RB, Kaplan MS. Behavioral and psychopharmacological treatment of the paraphilic and hypersexual disorders. J PsychiatrPract 2002;8(1):21-32. • Marshall WL. Diagnostic issues, multiple paraphilias, and comorbid disorders in sexual offenders: The irincidence and treatment. Aggression and Violent Behavior 12 (2007) 16–35. • Mews A, DiBella L, Purver M. Impacte valuation of the prison-based Core Sex Offender Treatment Program. Ministry of Justice Analytic Series. London: Crown; 2017. • Montejo AI, Llorce G, Izquierdo JA, Rico-Villademoros F, et al. Incidence of sexual dysfunction associated to different antidepressantagents. A prospective and multicentric study in 1022 patients. J Clin Psychiatry 2001;62(Suppl 3):10-21. • Naylor AM. Endogenous neurotransmitters mediating penile erection. Br J Urol 1998;81:424- 31. • Osborn C, Wise TN. Hand book of sexual dysfunction. Boca Raton: Taylor & Francis; 2005. • Redouté J, Stoléru S, Grégoire MC, Costes N, Cinotti L, Lavenne F, Le Bars D, Forest MG, Pujol JF. Brain Processing of Visual Sexual Stimuli in Human Males. Human Brain Mapping 2000;11:162–177. • Rosler A, Witztum E. Treatment of men with paraphilia with a long-actinganalogue of gonadotropin-releasing hormone. N Engl J Med 1998;338(7):416-22. • Rubenstein EB, Engel NL. Successful treatment of travestic fetischism with sertraline and lithium. J Clin Psychiatry 1996;57(2):92. • Ryback RS. Naltrexone in the treatment of adolescent sexual offenders. J Clin Psychiatry 2004;65(7):982-6. • Serreti A, Chiesa A. A meta-analysisof sexual dysfunction in psychistric patients taking antipsychotics. Int Clin Psychopharmacol 2011;26:130-140. • Shiah IS, Chao CY, Mao WC Chuang YJ. Treatment of paraphilic sexual disorder: the use oftopiramate in fetischism. Int Clin Psychopharmacol 2006;21(4):241-3. Takahashi A, Quadros IM, Almeida RMM de, Miczek KA. Behavioral and Pharmacogenetics of Aggressive Behavior. Curr Top Behav Neurosci 2012; 12: 73–138. • Thibaut F, de la Barra F, Gordon H, Cosyns P, Bradford JM. WFSBP Task Forceob Sexual Disorders. The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of paraphilias. World J Biol Psychiatry 2010;11(4):604-55. • Varela D, Black DW. Pedophilia treated withcarbamazepine and clonazepam. Am J Psychiatry 2002;159(7):1245-6. • Waldinger MD, Zwinderman AH, Oliver B. Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with mirtazapine and paroxetine. J Clin Psychopharmacol 2003;23:467-70. • Waldinger MD, Zwinderman AH, Oliver B. SS- RIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram. J Clin Psychopharmacol 2001;21:556-60. • Wittels, F Sigmund Freud: su personalidad, su enseñanza y su escuela. Londres, 1924, p. 17. 16 // EDITORIAL SCIENS
